首页> 外文期刊>Clinical nuclear medicine >Metastatic Insulinoma Controlled by Targeted Radionuclide Therapy With Lu-177-DOTATATE in a Patient With Solitary Kidney and MEN-1 Syndrome
【24h】

Metastatic Insulinoma Controlled by Targeted Radionuclide Therapy With Lu-177-DOTATATE in a Patient With Solitary Kidney and MEN-1 Syndrome

机译:通过孤立肾和男性1综合征的患者患者靶向放射性核素治疗的转移性胰岛素瘤治疗。

获取原文
获取原文并翻译 | 示例
           

摘要

A 54-year-old man with multiple endocrine neoplasia type 1 had previous history of parathyroid surgery and left thyroid lobectomy 5 years earlier, and was referred for recurrent hypoglycemic episodes. Ga-68-DOTATATE PET/CT had showed multiple lesions in the right lung, liver, and pancreas. Biopsy from pancreas revealed low-grade neuroendocrine neoplasia. After 2 fractions of Lu-177-DOTATATE therapy, the size of lesions and its activity reduced on the Ga-68-DOTATATE scan and the hypoglycemic episodes manifested every day have scaled down to 1 time over 1-year follow-up. Herein, we report a case of malignant insulinoma successfully treated with radiolabeled somatostatin receptor therapy using Lu-177-DOTATATE.
机译:一名54岁的男子患有多个内分泌瘤形成1型,患有甲状旁腺手术的先前历史和5年前的甲状腺肺切除术病史,并提到了复发性低血糖发作。 Ga-68-致乳酸盐/ CT在右肺,肝脏和胰腺中显示出多个病变。 来自胰腺的活组织检查显示出低级神经内分泌瘤形成。 在2分之后的Lu-177-致乳酸疗法后,病变的大小及其活性减少了GA-68-致乳酸扫描,并且每天表现出的低血糖发作量减少到1次超过1年的随访时间。 在此,我们通过使用Lu-177-致乳酸盐成功地用放射性标记的生长抑制菌素受体治疗成功处理了恶性胰岛素瘤的情况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号